Google Alert - Ebola

	Ebola As-it-happens update ⋅ July 6, 2017
	NEWS
	Inovio's DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle Validation GlobeNewswire (press release) We look forward to advancing the first dMAb product – our therapeutic Ebola product funded by DARPA – into human testing in 2018." While Inovio is ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback